BornToGetThere (2020–2024) focused on implementing early detection and early intervention service delivery for infants at risk for cerebral palsy, representing their most recent and best-funded project at EUR 349,400.
HUBSTRACT SRL
Italian technology SME contributing specialist expertise in early clinical detection and connected maritime systems to European research consortia.
Their core work
HUBSTRACT SRL is a small Italian technology company based in Pisa that contributes specialist capabilities to European research consortia across distinct applied domains. Their participation in LINCOLN (2016–2019) placed them in the maritime innovation space — connected, lean vessel systems — while their subsequent involvement in BornToGetThere (2020–2024) pivoted sharply toward pediatric clinical technology, specifically early detection and intervention tools for infants at risk of cerebral palsy. This cross-domain profile suggests HUBSTRACT brings transferable technical or methodological expertise — likely in digital systems, data processing, or sensor integration — that research consortia find valuable independent of sector. With only two recorded projects, their precise core competency remains difficult to pin down, but they appear to operate as a specialist contributor rather than a research generalist.
What they specialise in
LINCOLN (2016–2019) addressed lean, innovative, connected vessel design within the Blue Growth & Marine sector, contributing EUR 138,250 in EC funding to HUBSTRACT.
Participation in two technically unrelated sectors — maritime systems and pediatric health diagnostics — implies a transferable technical layer, likely digital or instrumentation-based, applied across both projects.
How they've shifted over time
HUBSTRACT's first H2020 project (2016–2019) placed them squarely in the Blue Growth domain, working on connected vessel technology with no recorded health-sector keywords. By 2020, their focus had shifted entirely: the BornToGetThere project is anchored in cerebral palsy, early detection, and clinical intervention — a completely different application domain. This is either a strategic pivot toward health technology or evidence that HUBSTRACT contributes a generic technical capability (software, data systems, or instrumentation) that different consortium leaders recruit for different problems.
HUBSTRACT appears to be moving toward health technology and clinical diagnostics, with their most recent and largest project centered on infant neurological screening — suggesting future collaborations in digital health, assistive technology, or early intervention platforms are most likely.
How they like to work
HUBSTRACT has never coordinated an H2020 project, always joining as a participant — indicating they function as a recruited specialist rather than a consortium architect. Despite only two projects, they have engaged with 24 unique partners across 11 countries, which is notably broad for an SME of their size and suggests they bring a specific capability that diverse consortia seek out. There is no evidence of repeated partnerships, so they appear to work opportunistically rather than maintaining a fixed network of collaborators.
HUBSTRACT has built a surprisingly wide network for a two-project SME — 24 unique consortium partners spread across 11 countries. This breadth relative to their project count suggests each consortium they joined was large and internationally diverse.
What sets them apart
HUBSTRACT is an Italian SME that has demonstrated the ability to contribute usefully to research consortia in two entirely unrelated sectors — maritime innovation and pediatric health diagnostics — which is unusual and hints at transferable technical capabilities that generalize across problem domains. For consortium builders, this makes them a potentially flexible partner when a specific niche skill is needed without sector lock-in. However, with only two projects on record and no coordinator experience, any assessment of their depth in either domain should be treated with caution until more evidence is available.
Highlights from their portfolio
- BornToGetThereTheir largest project by EC funding (EUR 349,400) and most recent work, focused on a high-impact clinical challenge — early detection and intervention for infants at risk of cerebral palsy — within a multi-country Implementation Action.
- LINCOLNTheir earliest H2020 participation, in the Blue Growth & Marine sector, demonstrating an ability to operate outside health domains and pointing to cross-sector technical versatility.